Skip to main content

ZBTB8A Antibody

Novus Biologicals, part of Bio-Techne | Catalog # NBP3-29578

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP3-29578

Key Product Details

Species Reactivity

Human

Applications

Immunoprecipitation, Western Blot

Label

Unconjugated

Antibody Source

Polyclonal Rabbit IgG

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

Product Specifications

Immunogen

between 350 and 400

Clonality

Polyclonal

Host

Rabbit

Isotype

IgG

Applications for ZBTB8A Antibody

Application
Recommended Usage

Immunoprecipitation

Optimal dilutions of this antibody should be experimentally determined.

Western Blot

Optimal dilutions of this antibody should be experimentally determined.

Formulation, Preparation, and Storage

Purification

Affinity purified

Formulation

Tris-buffered Saline 0.1% BSA

Preservative

0.09% Sodium Azide

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C. Do not freeze.

Background: ZBTB8A

ZBTB8A may be involved in transcriptional regulation

Alternate Names

BOZ-F1, BOZF1BTB/POZ and zinc-finger domains factor on chromosome 1, BTB/POZ and zinc-finger domain-containing factor, FLJ90065, MGC17919, ZBTB8, zinc finger and BTB domain containing 8, zinc finger and BTB domain containing 8A, zinc finger and BTB domain-containing protein 8A, ZNF916A

Gene Symbol

ZBTB8A

Additional ZBTB8A Products

Product Documents for ZBTB8A Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for ZBTB8A Antibody

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...